← Open Payments lookup

BRYAN HYLER: Open Payments

NPI 1811218092 · VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,150 in 44 payments from 11 companies in 2025. Trend: 2023 $3,546 · 2024 $2,824 · 2025 $2,150

Food & beverage: $2,150
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$485
Alkermes, Inc.5$379
Neurocrine BioSciences, Inc.2$244
Axsome Therapeutics, Inc.3$239
Otsuka America Pharmaceutical, Inc.5$183
Vanda Pharmaceuticals Inc.2$135
ABBVIE INC.1$125
Teva Pharmaceuticals USA, Inc.1$121
Lilly USA, LLC1$116
Janssen Pharmaceuticals, Inc1$106

Products named: CAPLYTA, INGREZZA, LYBALVI, Auvelity, REXULTI, ARISTADA, FANAPT, VRAYLAR.

Industry payments across CA — which companies pay providers there.